These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 4053551)

  • 1. [Acute unusual hemodynamic effects of the calcium-antagonists].
    Bruzzese V; Coccia G; Di Bartolomeo R; Fiorini G; Rossi A; Ruggieri P
    Clin Ter; 1985 Sep; 114(5):393-9. PubMed ID: 4053551
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of calcium antagonists on thyrotropin and thyroid hormone secretion.
    Zofková I; Blahos J; Bednár J
    Endokrinologie; 1982 Oct; 80(2):231-4. PubMed ID: 6819132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound sinus bradycardia due to diltiazem, verapamil, and/or beta-adrenergic blocking drugs.
    Mills TA; Kawji MM; Cataldo VD; Pappas ND; O'Meallie LP; Breaux DM; Glancy DL
    J La State Med Soc; 2004; 156(6):327-31. PubMed ID: 15688675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium ion blocking drugs.
    Resnekov L
    Compr Ther; 1982 Jul; 8(7):10-5. PubMed ID: 7116804
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of hemodynamic changes on the elimination kinetics of verapamil and nifedipine.
    Hamann SR; Blouin RA; Chang SL; Kaltenborn KE; Tan TG; McAllister RG
    J Pharmacol Exp Ther; 1984 Nov; 231(2):301-5. PubMed ID: 6491984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of calcium ion antagonists.
    Eichelbaum M
    Clin Invest Med; 1980; 3(1-2):13-7. PubMed ID: 7471537
    [No Abstract]   [Full Text] [Related]  

  • 8. Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA).
    Pahor M; Manto A; Pedone C; Carosella L; Guralnik JM; Carbonin P
    J Clin Epidemiol; 1996 Aug; 49(8):921-8. PubMed ID: 8699214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse Drug Reactions Advisory Committee. Gynaecomastia in association with calcium antagonists.
    Boyd IW
    Med J Aust; 1994 Sep; 161(5):328. PubMed ID: 7830672
    [No Abstract]   [Full Text] [Related]  

  • 11. [The comparative efficacy of verapamil, nifedipine and propranolol in patients with IHD and an enhanced risk of a fatal outcome].
    Mazur NA; Pavlova TS; Vasil'eva NN; Kul'ginskaia IV
    Ter Arkh; 1994; 66(8):26-30. PubMed ID: 7527161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium antagonists in myocardial and smooth muscle physiology. Relation to its therapeutic use].
    Kabela E
    Arch Inst Cardiol Mex; 1980; 50(5):533-4. PubMed ID: 7469596
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical differentiation of nifedipine and other calcium antagonists.
    Ebner F; Donath M; Rämsch KD
    Arq Bras Cardiol; 1984 Jul; 43(1):5-12. PubMed ID: 6395839
    [No Abstract]   [Full Text] [Related]  

  • 14. [Side-effects of calcium antagonists].
    Fossati C; Guistiniani S
    Clin Ter; 1984 Jun; 109(6):569-74. PubMed ID: 6236948
    [No Abstract]   [Full Text] [Related]  

  • 15. Gingival hyperplasia due to calcium antagonists.
    Prescrire Int; 1998 Apr; 7(34):54-5. PubMed ID: 10183386
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sinus bradycardia with junctional rhythm escape reverted with calcium gluconate].
    de Cleva R; Gontow N; de Brito FS; Besen D
    Arq Bras Cardiol; 1994 May; 62(5):347-9. PubMed ID: 7998868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interaction between beta receptor blockaders and verapamil].
    Ljungström A; Aberg H
    Lakartidningen; 1973 Oct; 70(41):3548. PubMed ID: 4801798
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-term treatment with calcium antagonists: advantageous effects and risks].
    van Zwieten PA; Tijssen JG; Lie KI; de Leeuw PW
    Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2715-21. PubMed ID: 8569884
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic uses of calcium-blocking agents:verapamil, nifedipine, and diltiazem.
    Schwartz DJ; Wasserstrom JA; Fozzard HA
    Compr Ther; 1981 Oct; 7(10):25-33. PubMed ID: 7297044
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical pharmacokinetics of calcium channel antagonists.
    McAllister RG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S340-5. PubMed ID: 6184565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.